| Literature DB >> 26559567 |
Robert M Jacobson1, Amenah A Agunwamba2, Jennifer L St Sauver2, Lila J Finney Rutten2.
Abstract
The US is failing to make substantive progress toward improving rates of human papillomavirus vaccine uptake. While the Healthy People 2020 goal for human papillomavirus (HPV) vaccination is 80%, the three-dose completion rate in the US in 2014 for 13- to 17-year-old females is less than 40%, and the rate for males is just above 20%. Experts point to a number of reasons for the poor HPV vaccination rates including parental concerns about safety, necessity, and timing. However, the evidence refuting these concerns is substantial. Efforts focusing on education and communication have not shown promise, but several population health strategies have reminder/recall systems; practice-focused strategies targeting staff, clinicians, and parents; assessment and feedback activities; and school-based HPV vaccination programs.Entities:
Keywords: Papillomavirus vaccines; United States; adolescent; child; health knowledge, attitudes, practice; immunization; immunization programs; vaccination
Mesh:
Substances:
Year: 2015 PMID: 26559567 PMCID: PMC6684098 DOI: 10.1586/14760584.2016.1116947
Source DB: PubMed Journal: Expert Rev Vaccines ISSN: 1476-0584 Impact factor: 5.217